Tranxamic acid in cervical ectropio
Phase 3
- Conditions
- Cervical ectropion.Erosion and ectropion of cervix uteri
- Registration Number
- IRCT20220115053719N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 88
Inclusion Criteria
Patients who have been diagnosed with cervical ectropion by an experienced gynecologist.
Exclusion Criteria
Pregnancy
Having any known malignancy
Patients in the Menopause period
Intrauterine device (IUD)
Taking contraceptives in the recent 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pelvic pain. Timepoint: Patients' pain will be evaluated at intervals of zero, the seventh day, the fourteenth day, the twenty-first day, the twenty-eighth day, the sixtieth day and the ninetieth day. Method of measurement: Visual Analogue Scale will be used to determine the pain.
- Secondary Outcome Measures
Name Time Method